Skip to content

A Pilot Study of Cardiometabolic Health Nursing in a Community Mental Health Service.

Amongst adult community mental health service consumers, is a Cardiometabolic Health Nurse more effective than usual care for improving access to primary care and self-reported health?

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000801819
Enrollment
154
Registered
2012-07-31
Start date
2012-10-15
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary aim of this six-month randomised controlled trial (RCT) is to determine whether access to a cardiometabolic health nurse (CHN) results in improved primary care for the prevention and treatment of cardiometabolic disorders such as cardiovascular disease and diabetes, compared to usual care in a regional Queensland mental health service. The secondary aim is to determine whether the CHN group demonstrate improvements in objectively-assessed and self-reported physical and mental health. We hypothesise that: 1. Greater numbers of primary health care services for cardiometabolic health disorders will be provided to the CHN care group than the usual care group during the six-month intervention. 2. Greater improvements in measures of physical and mental health will be observed in the CHN care group over the six-month intervention compared to the usual care group, and the CHN care group will also demonstrate improvements in health behaviours.

Interventions

An experienced clinical nurse will be appointed to the Cardiometabolic Health Nurse (CHN) position for the six-month trial. Participants randomly allocated to CHN care will attend a baseline CHN appointment involving cardiometabolic assessments including body mass index and waist-hip ratio, health behaviour assessments (eg diet and physical activity), blood pressure, and reviews of cardiometabolic and antipsychotic medication adherence and side-effects. During the subsequent 24-week intervention

An experienced clinical nurse will be appointed to the Cardiometabolic Health Nurse (CHN) position for the six-month trial. Participants randomly allocated to CHN care will attend a baseline CHN appointment involving cardiometabolic assessments including body mass index and waist-hip ratio, health behaviour assessments (eg diet and physical activity), blood pressure, and reviews of cardiometabolic and antipsychotic medication adherence and side-effects. During the subsequent 24-week intervention, the CHN will manage primary care of participants through strategies such as organising further CHN consultations or telephone appointments, providing health behaviour education, and organising referrals to other health professionals and ensuring that these linkages are maintained. All CHN participants will attend a follow-up appointment 24 weeks after their baseline appointment.

Sponsors

Brenda Happell
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Adult accessing community mental health services at the Central Queensland Mental Health Service.

Exclusion criteria

Incapable of providing informed consent English not a first language

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026